A critical review and discussion of analytical methods in the l-arginine/nitric oxide area of basic and clinical research

Analytical Biochemistry

Volumn 379, Issue 2, 2008, Pages 139-163

  Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS;

ANALYTICAL METHOD; CRITICAL REVIEW; L-ARGININE; OXIDE AREA;

CLINICAL RESEARCH;

3 NITRO 4 HYDROXYPHENYLACETIC ACID; 3 NITROTYROSINE; ARGININE; DIMETHYLAMINE; DITYROSINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHENYLACETIC ACID DERIVATIVE; S NITROSOTHIOL; TYROSINE DERIVATIVE;

ANALYTIC METHOD; CLINICAL RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; GAS CHROMATOGRAPHY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 45849096877     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.04.018     Document Type: Review

References (318)

1. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
2. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
3. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
4. Marletta M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268 (1993) 12231-12234
5. Feldman P.L., Griffith O.W., and Stuehr D.J. The surprising life of nitric oxide. Chem. Eng. News 71 (1993) 26-38
6. Förstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., and Kleinert H. Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions. Hypertension 23 (1994) 1121-1131
7. Moncada S., and Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9 (1995) 1319-1330
8. Andrew P.J., and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 43 (1999) 521-531
9. Leiper J., and Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res. 43 (2003) 542-548
10. Moncada S., and Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147 Suppl. 1 (2006) S193-S201
11. Ellis G., Adatia I., Yazdanpanah M., and Makela S.K. Nitrite and nitrate analyses: A clinical biochemistry perspective. Clin. Biochem. 31 (1998) 195-220
12. M Tarpey M., and Fridovich I. Methods of detection of vascular reactive species: Nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89 (2001) 224-236
13. Tsikas D. Analysis of the l-arginine/nitric oxide pathway: The unique role of mass spectrometry. Curr. Pharm. Anal. 1 (2005) 15-30
14. Boudko D. Bioanalytical profile of the l-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis. J. Chromatogr. B 851 (2007) 186-210
15. Thum T., and Bauersachs J. Microarray-based gene expression profiling to elucidate cellular response to nitric oxide: A review from an analytical and biomedical point of view. J. Chromatogr. B 851 (2007) 3-11
16. Giustarini D., Milzani A., Dalle-Donne I., and Rossi R. Detection of S-nitrosothiols in biological fluids: A comparison among the most widely applied methodologies. J. Chromatogr. B 851 (2007) 124-139
17. Ryberg H., and Caidahl K. Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples. J. Chromatogr. B 851 (2007) 160-171
18. Hibbs Jr. J.B., Westenfelder C., Taintor R., Vavrin Z., Kablitz C., Baranowski R.L., Ward J.H., Menlove R.L., McMurry M.P., Kushner J.P., and Samlowski W.E. Evidence for cytokine-inducible nitric oxide synthesis from l-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89 (1992) 867-877
19. Iyengar R., Stuehr D.J., and Marletta M.A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: Precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84 (1987) 6369-6373
20. Förstermann U. Endothelial NO synthase as a source of NO and superoxide. Eur. J. Clin. Pharmacol. 62 (2006) 5-12
21. Schmidt H.H.H.W., Hofmann H., Schindler U., Shutenko Z.S., Cunninghamm D.D., and Feelisch M. No NO from NO synthase. Proc. Natl. Acad. Sci. USA 93 (1996) 14492-14497
22. Tsikas D., Böger R.H., Sandmann J., Bode-Böger S.M., and Frölich J.C. Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett. 478 (2000) 1-3
23. Cooke J.P. Asymmetric dimethylarginine (ADMA): An endogenous inhibitor of angiogenesis. Eur. J. Clin. Pharmacol. 62 (2006) 115-121
24. Lenzen H., Tsikas D., and Böger R.H. Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease: The multicenter CARDIAC study. Eur. J. Clin. Pharmacol. 62 (2006) 45-49
25. Leiper J.M., and Vallance P. The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur. J. Clin. Pharmacol. 62 (2006) 33-38
26. Kelm M., and Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 66 (1990) 1561-1575
27. Gladwin M.T., Schechter A.N., Kim-Shapiro D.B., Patel R.P., Hogg N., Shiva S., Cannon R.O., Kelm M., Wink D.A., Espey M.G., Oldfield E.H., Pluta R.M., Freeman B.A., Lancaster J.R., Feelisch M., and Lundberg J.O. The emerging biology of the nitrite anion. Nat. Chem. Biol. 1 (2005) 308-314
28. Tsikas D., Gutzki F.-M., and Stichtenoth D.O. Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: Methods of analysis. Eur. J. Clin. Pharmacol. 62 (2006) 51-59
29. Park K.S., Lee H.W., Hong S.Y., Shin S., Kim S., and Paik W.K. Determination of methylated amino acids in human serum by high-performance liquid chromatography. J. Chromatogr. A 440 (1988) 225-230
30. Pettersson A., Uggla L., and Backman V. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J. Chromatogr. B 692 (1997) 257-262
31. Meyer J., Richter N., and Hecker M. High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo. Anal. Biochem. 247 (1997) 11-16
32. Tsikas D., Junker W., and Frölich J.C. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J. Chromatogr. B 705 (1998) 174-176
33. Pi J., Kumagai Y., Sun G., and Shimojo N. Improved method for simultaneous determination of l-arginine and its mono- and dimethylated metabolites in biological samples by high-performance liquid chromatography. J. Chromatogr. B 742 (2000) 199-203
34. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal. Biochem. 303 (2002) 131-137
35. Marra M., Bonfigli A.R., Testa R., Testa I., Gambini A., and Coppa G. High-performance liquid chromatographic assay of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine in human plasma by derivatization with naphthalene-2,3-dicarboxaldehyde. Anal. Biochem. 318 (2003) 13-17
36. Zhang W.Z., and Kaye D.M. Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization. Anal. Biochem. 326 (2004) 87-92
37. ′-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J. Chromatogr. B 805 (2004) 325-329
38. ′-dimethyl-l-arginine using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent reagent. J. Chromatogr. A 1066 (2005) 41-45
39. de Jong S., and Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal. Biochem. 353 (2006) 287-289
40. Caussé E., Siri N., Arnal J.F., Bayle C., Malatray P., Valdiguié P., Salvayre R., and Couderc F. Determination of asymmetrical dimethylarginine by capillary-electrophoresis-laser-induced fluorescence. J. Chromatogr. B 741 (2000) 77-83
41. Tsikas D., Schubert B., Gutzki F.M., Sandmann J., and Frölich J.C. Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J. Chromatogr. B 798 (2003) 87-99
42. G-dimethyl-l-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry. J. Chromatogr. B 809 (2004) 59-65
43. Vishwanathan K., Tackett R.L., Stewart J.T., and Bartlett M.G. Determination of arginine and methylated arginines in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 748 (2000) 157-166
44. Martens-Lobenhoffer J., and Bode-Böger S.M. Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation. J. Chromatogr. B 798 (2003) 231-239
45. Martens-Lobenhoffer J., Krug O., and Bode-Böger S.M. Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique. J. Mass Spectrom. 39 (2004) 1287-1294
46. Schwedhelm E., Tan-Andresen J., Maas R., Riederer U., Schulze F., and Böger R.H. Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin. Chem. 51 (2005) 1268-1271
47. Kirchherr H., and Kühn-Velten W.N. HPLC-tandem mass spectrometric method for rapid quantification of dimethylarginines in human plasma. Clin. Chem. 51 (2005) 249-252
48. Schwedhelm E., Maas R., Tan-Andresen J., Schulze F., Riederer U., and Böger R.H. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated derivatives in human and mouse plasma. J. Chromatogr. B 851 (2007) 211-219
49. Schulze F., Wesemann R., Schwedhelm E., Sydow K., Albsmeier J., Cooke J.P., and Böger R.H. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin. Chem. Lab. Med. 42 (2004) 1377-1383
50. Valtonen P., Karppi J., Nyyssönen K., Valkonen V.P., Halonen T., and Punnonen K. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J. Chromatogr. B 828 (2005) 97-102
51. Martens-Lobenhoffer J., Westphal S., Awiszus F., Bode-Böger S.M., and Luley C. Determination of asymmetric dimethylarginine: Liquid chromatography-mass spectrometry or ELISA?. Clin. Chem. 51 (2005) 2188-2189
52. Široká R., Trefil L., Rajdl D., Racek J., and Cibulka R. Asymmetric dimethylarginine: Comparison of HPLC and ELISA methods. J. Chromatogr. B 850 (2007) 586-587
53. van Eijk H.M.H., Luiking Y.C., and Deutz N.E.P. Methods using stable isotopes to measure nitric oxide (NO) synthesis in the l-arginine/NO pathway in health and disease. J. Chromatogr. B 851 (2007) 172-185
54. Schwedhelm E. Quantification of ADMA: Analytical approaches. Vasc. Med. 10 Suppl. 1 (2005) S89-S95
55. Teerlink T. Measurement of asymmetric dimethylarginine in plasma: Methodological considerations and clinical relevance. Clin. Chem. Lab. Med. 43 (2005) 1130-1138
56. Teerlink T. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol. Med. 108 (2005) 263-274
57. Teerlink T. HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluid. J. Chromatogr. B 851 (2007) 21-29
58. Martens-Lobenhoffer J., and Bode-Böger S.M. Chromatographic-mass spectrometric methods for the quantification of l-arginine and its methylated metabolites in biological fluids. J. Chromatogr. B 851 (2007) 30-41
59. Horowitz J.D., and Heresztyn T. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerations. J. Chromatogr. B 851 (2007) 42-50
60. Rath M., and Krantz Jr. J.C. Nitrites: VIII. Blood-nitrite content of man and other species. J. Pharmacol. Exp. Ther. 76 (1942) 27-32
61. 15N]nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
62. Kleinbongard P., Rassaf T., Dejam A., Kerber S., and Kelm M. Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol. 359 (2002) 158-168
63. Giustarini D., Dalle-Donne I., Colombo R., Milzani A., and Rossi R. Adaptation of the Griess reaction for detection of nitrite in human plasma. Free Radic. Res. 38 (2004) 1235-1240
64. Romitelli F., Santini S.A., Chierici E., Pitocco D., Gavazzi B., Amorini A.M., Lazzarino G., and Di Stasio E. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC, and ion-trap GC-MS: The importance of a correct removal of proteins in the Griess assay. J. Chromatogr. B 851 (2007) 257-267
65. Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the l-arginine/nitric oxide area of research. J. Chromatogr. B 851 (2007) 51-70
66. Utermahlen Jr. W.E., Mellini D.W., and Issaq H.J. Solid-phase extraction procedure for the clean-up of urine and gastric juice specimens for nitrite and nitrate analysis by ion chromatography. J. Liquid Chromatrogr. 15 (1992) 3315-3322
67. Everett S.A., Dennis M.F., Tozer G.M., Prise V.E., Wardman P., and Stratford M.R.L. Nitric oxide in biological fluids: Analysis of nitrite and nitrate by high-performance ion chromatography. J. Chromatogr. A 706 (1995) 437-442
68. Preik-Steinhoff H., and Kelm M. Determination of nitrite in human blood by combination of a specific sample preparation with high-performance anion-exchange chromatography and electrochemical detection. J. Chromatogr. B 685 (1996) 348-352
69. Muscara M.N., and de Nucci G. Simultaneous determination of nitrite and nitrate anions in plasma, urine, and cell culture supernatants by high-performance liquid chromatography with post-column reactions. J. Chromatogr. B 686 (1996) 157-164
70. Di Matteo V., and Esposito E. Methods for the determination of nitrite by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. A 789 (1997) 213-219
71. Tsikas D., Rossa S., Sandmann J., and Frölich J.C. High-performance liquid chromatographic analysis of nitrite and nitrate in human plasma as S-nitroso-N-acetylcysteine with ultraviolet absorbance detection. J. Chromatogr. B 724 (1999) 199-201
72. Li H., Meininger C.J., and Wu G. Rapid determination of nitrite by reversed-phase high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B 746 (2000) 199-207
73. 3: Difference in human coronary circulation with severe atherosclerotic stenosis. Life Sci. 66 (2000) 173-184
74. Woitzik J., Abromeit N., and Schaefer F. Measurement of nitric oxide metabolites in brain microdialysates by a sensitive fluorometric high-performance liquid chromatography assay. Anal. Biochem. 289 (2001) 10-17
75. Smith C.C.T., Stanyer L., and Betteridge D.J. Evaluation of methods for the extraction of nitrite and nitrate in biological fluids employing high-performance anion-exchange liquid chromatography for their determination. J. Chromatogr. B 779 (2002) 201-209
76. Jedlickova V., Paluch Z., and Alusik S. Determination of nitrate and nitrite by high-performance liquid chromatography in human plasma. J. Chromatogr. B 780 (2002) 193-197
77. Tsikas D. Mass spectrometry-validated HPLC method for urinary nitrate. Clin. Chem. 50 (2004) 1259-1261
78. Jobgen W.S., Jobgen S.C., Li H., Meininger C.J., and Wu G. Analysis of nitrite and nitrate in biological samples using high-performance liquid chromatography. J. Chromatogr. B 851 (2007) 71-82
79. Grau M., Hendgen-Cotta U.B., Brouzos P., Drexhage C., Rassaf T., Lauer T., Dejam A., Kelm M., and Kleinbongard P. Recent methodological advances in the analysis of nitrite in the human circulation: Nitrite as a biochemical parameter of the l-arginine/NO pathway. J. Chromatogr. B 851 (2007) 106-123
80. Leone A.M., Francis P.L., Rhodes P., and Moncada S. A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis. Biochem. Biophys. Res. Commun. 200 (1994) 951-957
81. Meulemans A., and Delsenne F. Measurement of nitrite and nitrate levels in biological samples by capillary electrophoresis. J. Chromatogr. B 660 (1994) 401-404
82. Ueda T., Maekawa T., Sadamitsu D., Oshita S., Ogino K., and Nakamura K. The determination of nitrite and nitrate in human blood plasma by capillary zone electrophoresis. Electrophoresis 16 (1995) 1002-1004
83. Boudko D.Y., Cooper B.Y., Harvey W.R., and Moroz L.L. High-resolution microanalysis of nitrite and nitrate in neuronal tissues by capillary electrophoresis with conductivity detection. J. Chromatogr. B 774 (2002) 97-104
84. Tesch J.W., Rehg W.R., and Sievers R.E. Microdetermination of nitrates and nitrites in saliva, blood, water, and suspended particulates in air by gas chromatography. J. Chromatogr. 126 (1976) 743-755
85. 2 as internal standard. Biol. Mass Spectrom. 21 (1992) 97-102
86. 15N-labeled analogs. J. Chromatogr. B 661 (1994) 185-191
87. Rhodes P., Leone A.M., Francis P.L., Struthers A.D., Moncada S., and Rhodes P.M. The l-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem. Biophys. Res. Commun. 209 (1995) 590-596
88. Tsikas D., Gutzki F.M., Rossa S., Bauer H., Neumann C., Dockendorff K., Sandmann J., and Frölich J.C. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: Problems with the Griess assay-Solutions by gas chromatography-mass spectrometry. Anal. Biochem. 244 (1997) 208-220
89. Smythe G.A., Matanovic G., Yi D., and Duncan M.W. Trifluoroacetic anhydride-catalyzed nitration of toluene as an approach to the specific analysis of nitrate by gas chromatography-mass spectrometry. Nitric Oxide 3 (1999) 67-74
90. Tsikas D., Gutzki F.M., Sandmann J., Schwedhelm E., and Frölich J.C. Gas chromatographic-tandem mass spectrometric quantification of human plasma and urinary nitrate after its reduction to nitrite and derivatization to the pentafluorobenzyl derivative. J. Chromatogr. B 731 (1999) 285-291
91. Tsikas D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry. Anal. Chem. 72 (2000) 4064-4072
92. Kage S., Kudo K., and Ikeda N. Determination of nitrate in blood by gas chromatography and gas chromatography-mass spectrometry. J. Chromatogr. B 742 (2000) 363-368
93. Kage S., Kudo K., and Ikeda N. Simultaneous determination of nitrate and nitrite in human plasma by gas chromatography-mass spectrometry. J. Anal. Toxicol. 26 (2002) 320-324
94. Smythe G.A., and Matanovic G. Specific analysis of nitrate and nitrite by gas chromatography/mass spectrometry. Methods Enzymol. 359 (2002) 148-157
95. Helmke S.M., and Duncan M.W. Measurement of the NO metabolites, nitrite and nitrate, in human biological fluids by GC-MS. J. Chromatogr. B 851 (2007) 83-92
96. Cox R. Determination of nitrate and nitrite at the parts per billion level by chemiluminescence. Anal. Chem. 52 (1980) 332-335
97. Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N.S., Jourd'heuil D., and Kelm M. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: Implications for the fate of NO in vivo. FASEB J. 16 (2002) 1775-1785
98. Pelletier M.M., Kleinbongard P., Ringwood L., Hito R., Hunter C.J., Schechter A.N., Gladwin M.T., and Dejam A. The measurement of blood and plasma nitrite by chemiluminescence: Pitfalls and solutions. Free Radic. Biol. Med. 41 (2006) 541-548
99. MacArthur P.H., Shiva S., and Gladwin M.T. Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J. Chromatogr. B 851 (2007) 93-105
100. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic. Res. 39 (2005) 797-815
101. Minamiyama Y., Takemura S., and Inoue M. Albumin is an important vascular tonus regulator as a reservoir of nitric oxide. Biochem. Biophys. Res. Commun. 225 (1996) 112-115
102. Hilliquin P., Borderie D., Hernvann A., Menkes C.J., and Ekindjian O.G. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum. 40 (1997) 1512-1517
103. Marzinzig M., Nussler A.K., Stadler J., Marzinzig E., Barthlen W., Nussler N.C., Beger H.G., Morris S.M., and Brückner U.B. Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1 (1997) 177-189
104. Funai E.F., Davidson A., Seligman S.P., and Finlay T.H. S-Nitrosohemoglobin in the fetal circulation may represent a cycle for blood pressure regulation. Biochem. Biophys. Res. Commun. 239 (1997) 875-877
105. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal. Chem. 70 (1998) 2446-2453
106. Tyurin V.A., Liu S.X., Tyurina Y.Y., Sussman N.B., Hubel C.A., Roberts J.M., Taylor R.N., and Kagan V.E. Elevaletd levels of S-nitrosoalbumin in preeclampsia plasma. Circ. Res. 88 (2001) 1210-1215
107. Corradi M., Montuschi P., Donnelly L.E., Pesci A., Kharitonov S.A., and Barne P.J. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care Med. 163 (2001) 854-858
108. Milsom A.B., Jones C.J.H., Goodfellow J., Frenneaux M.P., Peters J.R., and James P.E. Abnormal metabolic fate of nitric oxide in type I diabetes mellitus. Diabetologia 45 (2002) 1515-1522
109. McMahon T.J., Moon R.E., Luschinger B.P., Carraway M.S., Stone A.E., Stolp B.W., Gow A.J., Pawloski J.R., Watke P., Singel D.J., Piantadosi C.A., and Stamler J.S. Nitric oxide in the human respiratory cycle. Nat. Med. 8 (2002) 711-717
110. Wlodek P., Kucharczyk J., Sokolowska M.M., Milkowski A., Markiewicz A., Smolenski O.B., and Wlodek L.B. Alteration in plasma levels of nonproteins, sulfhydryl compounds, and S-nitrosothiols in chronic renal failure. Clin. Chim. Acta 327 (2003) 87-94
111. Massy Z.A., Fumeron C., Borderie P.T., Tuppin P., Nguyen-Khoa T., Benott M.O., Jacquot C., Buisson C., Druecke T.B., Ekindjian O.G., Lacour B., and Iliou M.C. Increased plasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: A prospective study. J. Am. Soc. Nephrol. 15 (2004) 470-476
112. Ng E.S., Jourd'heuil D., McCord J.M., Hernandez D., Yasui M., Knight D., and Kubes P. Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ. Res. 94 (2004) 559-565
113. Beeh K.M., Beier J., Koppenhoefer N., and Buhl R. Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD. Chest 126 (2004) 1116-1122
114. Scharfstein J.S., Keaney Jr. J.F., Slivka A., Welch G.N., Vita J.A., Stamler J.S., and Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest. 94 (1994) 1432-1439
115. Akaike T., Inoue K., Okamoto T., Nishino H., Otagiri M., Fujii S., and Maeda H. Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography couplet with flow reactors of metals and Griess reagent. J. Biochem. 122 (1997) 459-466
116. Goldman R.K., Vlessis A.A., and Trunkey D.D. Nitrosothiol quantification in human plasma. Anal. Biochem. 259 (1998) 98-103
117. Tsikas D., Sandmann J., Holzberg D., Pantazis P., Raida M., and Frölich J.C. Determination of S-nitrosoglutathione in human and rat plasma by high-performance liquid chromatography with fluorescence and ultraviolet absorbance detection after precolumn derivatization with o-phthaldehyde. Anal. Biochem. 273 (1999) 32-40
118. Jourd'heuil D., Gray L., and Grisham M.B. S-Nitrosothiol formation in blood of lipopolysaccharide-treated rats. Biochem. Biophys. Res. Commun. 273 (2000) 22-26
119. Jourd'heuil D., Hallen K., Feelisch M., and Grisham M.B. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic. Biol. Med. 28 (2000) 409-417
120. Rossi R., Giustarini D., Milzani A., Colombo R., and Dalle-Donne I. Physiological levels of S-nitrosothiols in human plasma. Circ. Res. 89 (2001) e47
121. Stamler J.S., and Loscalzo J. Capillary zone electrophoretic detection of biological thiols and their S-nitrosated derivatives. Anal. Chem. 64 (1992) 779-785
122. Tsikas D., Böger R.H., Bode-Böger S.M., Brunner G., and Frölich J.C. Formation of S-nitroso compounds from sodium nitroprusside, nitric oxide, or nitrite and reduced thiols: Analysis by capillary isotachophoresis. J. Chromatogr. A 699 (1995) 363-369
123. 15N]nitrosoalbumin as internal standard. J. Chromatogr. B 726 (1999) 13-24
124. Tsikas D., Sandmann J., Rossa S., Gutzki F.M., and Frölich J.C. Gas chromatographic-mass spectrometric detection of S-nitroso-cysteine and S-nitroso-glutathione. Anal. Biochem. 272 (1999) 117-122
125. 2+ via intermediate formation of S-nitrosocysteine and nitric oxide. J. Chromatogr. B 772 (2002) 335-346
126. Ferranti P., Malorni A., Mamone G., Sannolo N., and Marino G. Characterisation of S-nitrosohemoglobin by mass spectrometry. FEBS Lett. 400 (1997) 19-24
127. Kluge I., Gutteck-Amsler U., Zollinger M., and Do K.Q. S-Nitrosoglutathione in rat cerebellum: Identification and quantification by liquid chromatography-mass spectrometry. J. Neurochem. 69 (1997) 2599-2607
128. Balazy M.J., Kaminski P.M., Mao K., Tan J., and Wolin M.S. S-Nitroglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide. J. Biol. Chem. 273 (1998) 32009-32015
129. Tsikas D., Raida M., Sandmann J., Rossa S., Forssmann W.G., and Frölich J.C. Electrospray ionization mass spectrometry of low-molecular-mass S-nitroso compounds and their thiols. J. Chromatogr. B 742 (2000) 99-108
130. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri C.R., and Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89 (1992) 7674-7677
131. Gaston B., Reilly J., Drazen J.M., Fackler J., Ramdev P., Arnelle D., Mullins M.E., Sugarbaker D.J., Chee C., Singel D.J., Loscalzo J., and Stamler J.S. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airway. Proc. Natl. Acad. Sci. USA 90 (1993) 10957-10961
132. Alpert C., Ramdev N., George D., and Loscalzo J. Detection of S-nitrosothiols and other nitric oxide derivatives by photolysis-chemiluminescence spectrometry. Anal. Biochem. 245 (1997) 1-7
133. Fang K., Ragsdale N.V., Carey R.M., Macdonald T., and Gaston B. Reductive assays for S-nitrosothiols: Implications for measurements in biological systems. Biochem. Biophys. Res. Commun. 252 (1998) 535-540
134. Ewing J.F., and Janero D.R. Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection. Free Radic. Biol. Med. 25 (1998) 621-628
135. Grasemann H., Gaston B., Fang K., Paul K., and Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J. Pediatr. 135 (1999) 770-772
136. Gladwin M.T., Shelhamer J.H., Schechter A.N., Pease-Fye M.E., Waclawiw M.A., Panza J.A., Ognibene F.P., and Cannon III R.O. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc. Natl. Acad. Sci. USA 97 (2000) 11482-11487
137. Marley R., Feelisch M., Holt S., and Moore K. A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic. Res. 32 (2000) 1-9
138. Gladwin M.T., Ognibene F.P., Pannell L.K., Nichols J.S., Pease-Fye M.E., Shelhamer J.H., and Schechter A.N. Relative role of heme nitrosylation and β-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc. Natl. Acad. Sci. USA 97 (2000) 9943-9948
139. Cannon III R.O., Schechter A.N., Panza J.A., Ognibene F.P., Pease-Fye M.E., Waclawiw M.A., Shelhamer J.H., and Gladwin M.T. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J. Clin. Invest. 108 (2001) 279-287
140. Moriel P., O'Pereira I.R., Bertolami M.C., and Abdalla D.S.P. Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?. Free Radic. Biol. Med. 30 (2001) 318-326
141. Ottesen L.H., Harry D., Frost M., Davies S., Khan K., Halliwell B., and Moore K. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic. Biol. Med. 31 (2001) 790-798
142. Napoli C., Aldini G., Wallache J.L., de Nigris F., Maffei R., Abete P., Bonaduce D., Condorelli G., Rengo F., Sica V., D'Armiento F.P., Mignogna C., de Rosa G., Condorelli M., Lerman L.O., and Ignarro L.J. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc. Natl. Acad. Sci. USA 99 (2002) 1689-1694
143. Rassaf T., Bryan N.S., Kelm M., and Feelisch M. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic. Biol. Med. 33 (2002) 1590-1596
144. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon III R.O., Schechter A.N., and Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8 (2002) 1383-1389
145. Rassaf T., Bryan N.S., Maloney R.E., Specian V., Kelm M., Kalyanaraman B., Rodriguez J., and Feelisch M. NO adducts in mammalian red blood cells: Too much or too little?. Nat. Med. 9 (2003) 481-482
146. Cosby K., Partovi K.S., Krawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon III R.O., and Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9 (2003) 1498-1505
147. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., and Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 101 (2004) 4308-4313
148. Datta B., Tufnell-Barrett T., A Bleasdale R., Jones C.J., Beeton I., Paul V., Frenneaux M., and James P. Red blood cell nitric oxide as an endocrine vasoregulator: A potential role in congestive heart failure. Circulation 109 (2004) 1339-1342
149. Wang X., Tanus-Santos J.E., Reiter C.D., Dejam A., Shiva S., Smith R.D., Hogg N., and Gladwin M.T. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. USA 101 (2004) 11477-11482
150. James P.E., Lang D., Tufnell-Barret T., Milsom A.B., and Frenneaux M.P. Vasorelaxation by red blood cells and impairment in diabetes: Reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ. Res. 94 (2004) 976-983
151. 2 gradients. Proc. Natl. Acad. Sci. USA 102 (2005) 5709-5714
152. Mc Mahon T.J., Aheam G.S., Moya M.P., Gow A.J., Huang Y.C., Luchsinger B.P., Nudelman R., Yan Y., Krichman A.D., Bashore T.M., Califf R.M., Singel D.J., Piantadosi C.A., Tapson V.F., and Stamler J.S. A nitric oxide processing defect of red blood cells created by hypoxia: Deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc. Natl. Acad. Sci. USA 102 (2005) 14801-14806
153. Pawloski J.R., Hess D.T., and Stamler J.S. Impaired vasodilation by red blood cells in sickle cell disease. Proc. Natl. Acad. Sci. USA 102 (2005) 2531-2536
154. Rocks S.A., Davies C.A., Hicks S.L., Webb A.J., Klocke R., Timmins G.S., Johnston A., Jawad A.S.M., Blake D.R., Benjamin N., and Winyard P.G. Measurement of S-nitrosothiols in extracellular fluids from healthy human volunteers and rheumatoid arthritis patients, using electron paramagnetic resonance spectrometry. Free Radic. Biol. Med. 39 (2005) 937-948
155. Wang X., Bryan N.S., MacArthur P.H., Rodriguez J., Gladwin M.T., and Feelisch M. Measurement of nitric oxide levels in the red cell. J. Biol. Chem. 281 (2006) 26994-27002
156. Pfeiffer S., Schrammel A., Schmidt K., and Mayer B. Electrochemical determination of S-nitrosothiols with a Clark-type nitric oxide electrode. Anal. Biochem. 258 (1998) 68-73
157. Rafikova O., Sokolova E., Rafikov R., and Nudler E. Control of plasma nitric oxide bioactivity by perfluorocarbons: Physiological mechanisms and clinical implications. Circulation 110 (2004) 3573-3580
158. Cha W., Lee Y., Oh B.K., and Meyerhoff M.E. Direct detection of S-nitrosothiols using planar amperometric nitric oxide sensor modified with polymeric films containing catalytic copper species. Anal. Chem. 77 (2005) 3516-3524
159. Jaffrey R., and Snyder S.H. The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE 2001 (2001) PL1-PL9
160. Zhang Y., Keszler A., Brniowska K.A., and Hogg N. Characterization of the biotin-switch assay for the identification of S-nitrosated proteins. Free Radic. Biol. Med. 38 (2005) 874-881
161. Gandley R.E., Tyurin V.A., Huang W., Arroyo A., Daftary A., Harger G., Jiang J., Pitt B., Taylor R.N., Hubel C.A., and Kagan V.E. S-Nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: Effects in pregnancy and preeclampsia plasma. Hypertension 45 (2005) 1-7
162. Kettenhofen N.J., Broniowska K.A., Keszler A., Zhang Y., and Hogg N. Proteomic methods for analysis of S-nitrosation. J. Chromatogr. B 851 (2007) 152-159
163. Gow A., Doctor A., Mannick J., and Gaston B. S-Nitrosothiol measurement in biological systems. J. Chromatogr. B 851 (2007) 140-151
164. Tsikas D. S-Nitrosoalbumin and other S-nitrosothiols in the blood: Is their quantity of no relevance?. Circ. Res. 94 (2004) e106
165. Tsikas D., and Frölich J.C. Trouble with the analysis of nitrite, nitrate, S-nitrosothiols, and 3-nitrotyrosine: freezing-induced artifacts?. Nitric Oxide 11 (2004) 209-213
166. Tsikas D. Quantitative determination of free and protein-associated 3-nitrotyrosine and S-nitrosothiols in the circulation by mass spectrometry and other methodologies: A critical review and discussion from the analytical and review point of view. In: Dalle-Donne I., Scaloni A., and Butterfield D.A. (Eds). Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases (2006), John Wiley, New York 287
167. Kamisaki Y., Wada K., Nakamoto K., Kishimoto Y., Kitano M., and Itoh T. Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography. J. Chromatogr. B 685 (1996) 343-347
168. Fukuyama N., Takebayashi Y., Hida M., Ishida H., Ichimori K., and Nakazawa H. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic. Biol. Med. 22 (1997) 771-774
169. Ohshima H., Celan I., Chazotte L., Pignatelli B., and Mower H.F. Analysis of 3-nitrotyrosine in biological fluids and protein hydrolyzates by high-performance liquid chromatography using a portseparation, on-line reduction column and electrochemical detection: Results with various nitrating agents. Nitric Oxide 3 (1999) 132-141
170. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., and Isobe C. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 46 (1999) 129-131
171. Sodum R.S., Akerkar S.A., and Fiala E.S. Determination of 3-nitrotyrosine by high-performance liquid chromatography with a dual-mode electrochemical detector. Anal. Biochem. 280 (2000) 278-285
172. Strand O.A., Leone A., Giercksky K.E., and Kirkeboen K.A. Nitric oxide indices in human septic shock. Crit. Care Med. 28 (2000) 2779-2785
173. Ohya M., Marukawa S., Inoue T., Ueno N., Hosohara K., Terada N., and Kosaka H. Plasma nitrotyrosine concentration relates to prognosis in human septic shock. Shock 18 (2002) 116-118
174. Fatouros I.G., Jamurtas A.Z., Villiotou V., Pouliopoulou S., Fotinakis P., Taxildaris K., and Deliconstantinos G. Oxidative stress responses in older men during endurance training and detraining. Med. Sci. Sports Exerc. 36 (2004) 2065-2072
175. Du M., Wu W., Ercal N., and Mam Y. Simultaneous determination of 3-nitrotyrosine o-, m-, and p-tyrosine in urine samples by liquid chromatography-ultraviolet absorbance detection with pre-column cloud point extraction. J. Chromatogr. B 803 (2004) 321-329
176. Richards D.A., Silva M.A., and Devall A.J. Electrochemical detection of free 3-nitrotyrosine: Application to microdialysis studies. Anal. Biochem. 351 (2006) 77-83
177. Maeso N., Cifuentes A., and Barbas C. Large-volume sample stacking-capillary electrophoresis used for the determination of 3-nitrotyrosine in rat urine. J. Chromatogr. B 809 (2004) 147-152
178. Jiang H., and Balazy M. Detection of 3-nitrotyrosine in human platelets exposed to peroxynitrite by a new gas chromatography/mass spectrometry assay. Nitric Oxide 2 (1998) 350-359
179. Schwedhelm E., Tsikas D., Gutzki F.M., and Frölich J.C. Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state. Anal. Biochem. 276 (1999) 195-203
180. Frost M.T., Halliwell B., and Moore K.P. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatogaphy/mass spectrometry method that avoids nitration artifacts. Biochem. J. 345 (2000) 453-458
181. Gaut J.P., Byun J., Tran H.D., and Heinecke J.W. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Biochem. 300 (2002) 252-259
182. Schwemmer M., Fink B., Köckerbauer R., and Bassenge E. How urine analysis reflects oxidative stress: Nitrotyrosine as a potential marker. Clin. Chim. Acta 297 (2000) 207-216
183. Söderling A.S., Ryberg H., Gabrielsson A., Larstad M., Toren K., Niari S., and Caidahl K. A derivatization assay using gas chromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. J. Mass Spectrom. 38 (2003) 1187-1196
184. Pannala A.S., Mani A.R., Spencer J.P., Skinner V., Bruckdorfer K.R., Moore K.P., and Rice-Evans C.A. The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic. Biol. Med. 34 (2003) 576-584
185. Tsikas D., Schwedhelm E., Stutzer F.K., Gutzki F.M., Rode I., Mehls C., and Frölich J.C. Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. J. Chromatogr. B 784 (2003) 77-90
186. Keimer R., Stutzer F.K., Tsikas D., Troost R., Gutzki F.M., and Frölich J.C. Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: A randomized, double-blind crossover study. J. Cardiovasc. Pharmacol. 41 (2003) 284-292
187. Mani A.R., Pannala A.S., Orie N.N., Ollosson R., Harry D., Rice-Evans C.A., and Moore K.P. Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine. Biochem. J. 374 (2003) 521-527
188. Tsikas D., Mitschke A., Suchy M.T., Gutzki F.M., and Stichtenoth D.O. Determination of 3-nitrotyrosine in human urine at the basal state by gas chromatography-tandem mass spectrometry and evaluation of the excretion after oral intake. J. Chromatogr. B 827 (2005) 146-156
189. Pannala A.S., Mani A.R., Rice-Evans C.A., and Moore K.P. pH-dependent nitration of para-hydroxyphenylacetic acid in the stomach. Free Radic. Biol. Med. 41 (2006) 896-901
190. Yi D., Ingelse B.A., Duncan M.W., and Smythe G.A. Quantification of 3-nitrotyrosine in biological tissues and fluids: Generating valid results by eliminating artifactual formation. J. Am. Soc. Mass Spectrom. 11 (2000) 578-586
191. Delatour T., Guy P.A., Stadler R.H., and Turesky R.J. 3-Nitrotyrosine butyl ester: A novel derivative to assess tyrosine nitration in rat plasma by liquid chromatography-tandem mass spectrometry detection. Anal. Biochem. 302 (2002) 10-18
192. Delatour T., Richoz J., Vuichoud J., and Stadler R.H. Artifactual nitration controlled measurement of protein-bound 3-nitro-l-tyrosine in biological fluids and tissues by isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry. Chem. Res. Toxicol. 15 (2002) 1209-1217
193. Ahmed N., Battah S., Karachalias N., Babaei-Jadidi R., Horanyi M., Baroti K., Hollan S., and Thornalley P.J. Increased formation of methylglyoxal and protein glycation, oxidation, and nitrosation in triosephosphate isomerase deficiency. Biochim. Biophys. Acta 1639 (2003) 121-132
194. Thornalley P.J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., and Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375 (2003) 581-592
195. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney Jr. J.F., Penn M.S., Sprecher D.L., Vita J.A., and Hazen S.L. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289 (2003) 1675-1680
196. Svatikova A., Wolk R., Wang H.H., Otto M.E., Bybee K.A., Singh R.J., and Somers V.K. Circulating free nitrotyrosine in obstructive sleep apnea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R284-R287
197. Delatour T. Performance of quantitative analyses by liquid chromatography-electrospray ionisation tandem mass spectrometry: From external calibration to isotopomer-based exact matching. Anal. Bioanal. Chem. 380 (2004) 515-523
198. Ahmed N., Babaei-Jadidi R., Howell S.K., Beisswenger P.J., and Thornalley P.J. Degradation products of proteins damaged by glycation, oxidation, and nitration in clinical type 1 diabetes. Diabetologia 48 (2005) 1590-1603
199. Nicholls S.J., Shen Z., Fu X., Levison B.S., and Hazen S.L. Quantification of 3-nitrotyrosine levels using a benchtop ion trap mass spectrometry method. Methods Enzymol. 396 (2005) 245-266
200. Goën T., Muller-Lux A., Dewes P., Musiol A., and Kraus T. Sensitive and accurate analyses of free 3-nitrotyrosine in exhaled breath condensate by LC-MS/MS. J. Chromatogr. B 826 (2005) 261-266
201. Orhan H., Coolen S., and Meerman J.H.N. Quantification of urinary o,o-dityrosine, a biomarker of oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometry: A comparison with ion-trap tandem mass spectrometry. J. Chromatogr. B 827 (2005) 104-108
202. Delatour T., Fenaille F., Parisod V., Richoz J., Vuichoud J., Mottier P., and Buetler T. A comparative study of proteolysis methods for the measurement of 3-nitrotyrosine residues: Enzymatic digestion versus hydrochloric acid-mediated hydrolysis. J. Chromatogr. B 851 (2007) 268-276
203. Khan J., Brennan D.M., Bradley N., Gao B., Bruckdorfer R., and Jacobs M. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J. 330 (1998) 795-801
204. ter Steege J.C.A., Koster-Kamphuis L., van Straaten E.A., Forget P.P., and Buurman W.A. Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic. Biol. Med. 25 (1998) 953-963
205. Oldreive C., Bradley N., Bruckdorfer R., and Rice-Evans C. Lack of influence of dietary nitrate/nitrite on plasma nitrotyrosine levels measured using a competitive inhibition of binding ELISA assay. Free Radic. Res. 35 (2001) 377-386
206. Söderling A.-S., Hultman L., Delbro D., Højrup P., and Caidahl K. Reduction of the nitro group during sample preparation may cause underestimation of the nitration level in 3-nitrotyrosine immunoblotting. J. Chromatogr. B 851 (2007) 277-286
207. Petersson A.-S., Steen H., Kalume D.E., Caidahl K., and Roepstorff P. Investigation of tyrosine nitration in proteins by mass spectrometry. J. Mass Spectrom. 36 (2001) 616-625
208. Sarver A., Scheffler N.K., Shetlar M.D., and Gibson B.W. Analysis of peptides and proteins containing nitrotyrosine by matrix-assisted laser desorption/ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 12 (2001) 439-448
209. Zhan X., and Desiderio D.M. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal. Biochem. 354 (2006) 279-289
210. Malencik D.A., Sprouse J.F., Swanson C.A., and Anderson S.R. Dityrosine: Preparation, isolation, and analysis. Anal. Biochem. 242 (1996) 202-213
211. Hensley K., Williamson K.S., and Floyd R.A. Measurement of 3-nitrotyrosine and 5-nitro-γ-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radic. Biol. Med. 28 (2000) 520-528
212. Duncan M.W. A review of approaches to the analysis of 3-nitrotyrosine. Amino Acids 25 (2003) 351-361
213. Tsikas D., and Caidahl K. Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma. J. Chromatogr. B 814 (2005) 1-9
214. Beal D.D., and Bryan G.T. Quantitative spectrophotometric determination of human and rat urinary dimethylamine. Biochem. Med. 19 (1978) 374-382
215. Achan V., Broadhead M., Malaki M., Whitley G.S.J., Leiper J., MacAllister R., and Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1455-1459
216. Baba S., Watanabe Y., Gejyo F., and Arakawa M. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin. Chim. Acta 136 (1984) 49-56
217. Teerlink T., Hennekes M.W.T., Mulder C., and Brulez H.F.H. Determination of dimethylamine in biological samples by high-performance liquid chromatography. J. Chromatogr. B 691 (1997) 269-276
218. Dabek-Zlotprzynska E., and Maruzak W. Determination of dimethylamine and other low-molecular-mass amines using capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. B 714 (1998) 77-85
219. Zhang A.Q., Mitchell S.C., Ayesh R., and Smith R.L. Determination of trimethylamine and related aliphatic amines in human urine by head-space gas chromatography. J. Chromatogr. 584 (1992) 141-145
220. Zhang A.Q., Mitchell S.C., Ayesh R., and Smith R.L. Dimethylamine in human urine. Clin. Chim. Acta 233 (1995) 81-88
221. Tsikas D., Thum T., Becker T., Pham V.V., Chobanyan K., Mitschke A., Beckmann B., Gutzki F.-M., Bauersachs J., and Stichtenoth D.O. Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: Evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. J. Chromatogr. B 851 (2007) 229-239
222. Chobanyan K., Mitschke A., Gutzki F.-M., Stichtenoth D.O., and Tsikas D. Accurate quantification of dimethylamine (DMA) in human plasma and serum by GC-MS and GC-tandem MS as pentafluorobenzamide derivative in the positive-ion chemical ionization mode. J. Chromatogr. B 851 (2007) 240-249
223. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84 (1987) 9265-9269
224. Plumb R.C., Edwards J.O., and Herman M.A. Problem of concurrent measurements of peroxonitrite and nitrite contents. Analyst 117 (1992) 1639-1641
225. . - interaction. J. Biol. Chem. 272 (1997) 9922-9932
226. Showeman D.W., and Nagasawa H.T. The reaction of nitroxyl (HNO) with nitrobenzene gives cupferron (N-nitrosophenylhydroxylamine). Nitric Oxide 2 (1998) 66-72
227. Marletta M.A., Yoon P.S., Iyengar R., Leaf C.D., and Wishnok J.S. Macrophage oxidation of l-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 27 (1988) 8706-8711
228. Lewis R.S., Deen W.M., Tannenbaum S.R., and Wishnok J.S. Membrane mass spectrometer inlet for quantitation of nitric oxide. Biol. Mass Spectrom. 22 (1993) 45-52
229. 2 chemiluminescence method. J. Biol. Chem. 268 (1993) 23106-23110
230. Radi R., Cosgrove T.P., Beckman J.S., and Freeman B.A. peroxynitrite-induced luminal chemiluminescence. Biochem. J. 290 (1993) 51-57
231. Wennmalm Å., Lanne B., and Petersson A.-S. Detection of endothelial-derived relaxing factor in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. Anal. Biochem. 187 (1990) 359-363
232. Malinski T., and Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358 (1992) 676-678
233. Vallance P., Patton S., Bhagat K., MacAllister R., Radomski M., Moncada S., and Malinski T. Direct measurement of nitric oxide in human beings. Lancet 345 (1995) 153-154
234. Kleschyov A.L., Mollnau H., Oelze M., Meinertz T., Huang Y., Harrison D.G., and Munzel T. Spin trapping of vascular nitric oxide using colloid Fe(II)-diethylthiocarbamate. Biochem. Biophys. Res. Commun. 275 (2000) 672-677
235. Archer S. Measurement of nitric oxide in biological models. FASEB J. 7 (1993) 349-360
236. Tsikas D., Gutzki F.-M., and Frölich J.C. Quantitation of members of the l-arginine/nitric oxide (NO) pathway. Rec. Res. Dev. Anal. Biochem. 2 (2002) 1-27
237. Kitamura Y., Kobayashi H., Tanishita K., and Oka K. In vivo nitric oxide measurements using a microcoaxial electrode. Methods Mol. Biol. 279 (2004) 35-43
238. Steerenberg P.A., and van Amsterdam J.G.C. Measurement of exhaled nitric oxide. Methods Mol. Biol. 279 (2004) 45-68
239. Kleschyov A.L., Wenzel P., and Munzel T. Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxide. J. Chromatogr. B 851 (2007) 12-20
240. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 264 (1989) 10205-10209
241. Kwon N.S., Nathan C.F., Gilker C., Griffith O.W., Matthews D.E., and Stuehr D.J. l-Citrulline production from l-arginine by macrophage nitric oxide synthase. J. Biol. Chem. 265 (1990) 13442-13445
242. +. Anal. Biochem. 227 (1995) 274-280
243. Imrich A., and Kobzik L. Fluorescence-based measurement of nitric oxide synthase activity in activated rat macrophages using dichlorofluorescein. Nitric Oxide 1 (1997) 359-369
244. Giraldez R.R., and Zweier J.L. An improved assay for measurement of nitric oxide synthase activity in biological tissues. Anal. Biochem. 261 (1998) 29-35
245. Arrigoni F.I., Vallance P., Haworth S.G., and Leiper J.M. Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation 107 (2003) 1195-1201
246. Leiper J., Nandi M., Torondel B., Murray-Rust J., Malaki M., O'Hara B., Rossiter S., Anthony S., Madhani M., Selwood D., Smith C., Wojciak-Stothard B., Rudiger A., Stidwill R., McDonald N.Q., and Vallance P. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat. Med. 13 (2007) 198-203
247. Pietta P.G., Mauri P.L., Bardana C., and Benazzi L. Assay of soluble guanylate cyclase activity by isocratic high-performance liquid chromatography. J. Chromatogr. B 690 (1997) 343-347
248. G-dimethyl-l-arginine in rat plasma and dimethylarginine dimethylaminohydrolase activity in rat kidney using a monolithic silica column. J. Chromatogr. B 843 (2006) 170-174
249. Fekkes D., and Voskuilen-Kooijman A. Quantitation of total biopterin and tetrahydrobiopterin in plasma. Clin. Biochem. 40 (2007) 411-413
250. Tsikas D., Sandmann J., Savva A., Luessen P., Böger R.H., Gutzki F.M., Mayer B., and Frölich J.C. Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J. Chromatogr. B 742 (2000) 143-153
251. Chobanyan K., Thum T., Zhu B., Mitschke A., Suchy M.-T., Gutzki F.-M., Beckmann B., Stichtenoth D.O., and Tsikas D. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): Evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. J. Chromatogr. B 858 (2007) 32-41
252. Maas R., Tan-Andreesen J., Schwedhelm E., Schulze F., and Böger R.H. A stable isotope-based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue. J. Chromatogr. B 851 (2007) 220-228
253. Maurer T.S., and Fung H.-L. Evaluation of nitric oxide synthase activity and inhibition kinetics by chemiluminescence. Nitric Oxide 4 (2000) 372-378
254. Wunder F., Stasch J.-P., Hütter J., Alonso-Alija C., Hüser J., and Lohrmann E. A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. Anal. Biochem. 339 (2005) 104-112
255. Wunder F., Buehler G., Hüser J., Mundt S., Bechem M., and Kalthof B. A cell-based nitric oxide reported assay useful for the identification and characterization of modulators of the nitric oxide/guanosine 3′,5′-cyclic monophosphate pathway. Anal. Biochem. 363 (2007) 219-227
256. Domino S.E., Tubb D.J., and Garbers D.L. Assay of guanylyl cyclase catalytic activity. Methods Enzymol. 195 (1991) 345-355
257. Hevel J.M., and Marletta M.A. Nitric-oxide synthase assays. Methods Enzymol. 233 (1994) 250-258
258. Werner E.R., Werner-Felmayer G., and Wachter H. High-performance liquid chromatographic methods for the quantification of tetrahydrobiopterin biosynthetic enzymes. J. Chromatogr. B 684 (1996) 51-58
259. Klatt P., Schmidt K., Werner E.R., and Mayer B. Determination of nitric oxide synthase cofactors: Heme, FAD, FMN, and tetrahydrobiopterin. Methods Enzymol. 268 (1996) 358-365
260. Conrad K.P., Powers R.W., Davis A.K., and Novak J. Citrulline is not the major product using the standard "NOS activity" assay on renal cortical homogenates. Am. J. Physiol. Reg. Integr. Comp. Physiol. 282 (2002) R303-R310
261. Tsikas D. Measurement of nitric oxide synthase activity in vivo and in vitro by gas chromatography-mass spectrometry. Methods Mol. Biol. 279 (2004) 81-103
262. Sutherland H., Zolle O., Khundkar R., Simpson A.W.M., Jarvis J.C., and Salmons S. A nonradioactive assay for nitric oxide synthase activity in tissue extracts. Methods Mol. Biol. 279 (2004) 105-111
263. Tsikas D. Assessment of nitric oxide biosynthesis and peroxynitrite formation within the central nervous system by measuring l-citrulline in the cerebrospinal fluid. J. Chromatogr. B 813 (2004) 359-361
264. Beckmann B., Gutzki F.M., and Tsikas D. Sensitivity enhancement of a GC-MS/MS method for circulating asymmetric dimethylarginine (ADMA) by plasma ultrafiltrate reduction. Anal. Biochem. 372 (2008) 264-266
265. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
266. G-dimethyl-l-arginine in 500 subjects. Eur. J. Clin. Invest. 35 (2005) 622-626
267. Lücke T., Kanzelmeyer N., Kemper M.J., Tsikas D., and Das A.M. Developmental changes in the l-arginine/nitric oxide pathway from infancy to adulthood: Plasma asymmetric dimethylarginine levels decrease with age. Clin. Chem. Lab. Med. 45 (2007) 1525-1530
268. Böger R.H., and Bode-Böger S.M. Is asymmetric dimethylarginine a novel marker of atherosclerosis?. Circulation 101 (2000) e160-e161
269. Moody A.J., and Shaw F.L. Reevaluation of the Griess reaction: How much of a problem is interference by nicotinamide nucleotides?. Anal. Biochem. 356 (2006) 154-156
270. Surdacki A., Tsikas D., Mayatepek E., and Frölich J.C. Elevated urinary excretion of nitric oxide metabolites in young infants with Zellweger syndrome. Clin. Chim. Acta 334 (2003) 111-115
271. Bode-Böger S.M., Böger R.H., Kielstein J.T., Löffler M., Schäffer J., and Frölich J.C. Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis. J. Invest. Med. 48 (2000) 125-132
272. Süto{combining double acute accent} T., Losonczy G., Qiu C., Hill C., Samsell L., Ruby J., Charon N., Venuto R., and Baylis C. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Intl. 48 (1995) 1272-1277
273. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layoff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., and Spector S. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 81 (1992) 309-312
274. Bryan N.S., and Grisham M.B. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic. Biol. Med. 43 (2007) 645-657
275. Giustarini D., Milzani A., Colombo R., Dalle-Donne I., and Rossi R. Nitric oxide, S-nitrosothiols, and hemoglobin: Is methodology the key?. Trends Pharmacol. Sci. 25 (2004) 311-316
276. Stamler J.S. S-Nitrosothiols in the blood: Roles, amounts, and methods of analysis. Circ. Res. 94 (2004) 414-417
277. Tsikas D., and Frölich J.C. S-Nitrosoalbumin plasma levels in health and disease: Facts or artifacts? Value of analytical chemistry in nitric oxide clinical research. Circ. Res. 90 (2002) e39
278. Tsikas D. Measurement of physiological S-nitrosothiols: A problem child and a challenge. Nitric Oxide 9 (2003) 53-55
279. Tsikas D., and Frölich J.C. Are plasma S-nitrosothiol levels elevated in chronic renal failure. Nephrol. Dial. Transplant. 18 (2003) 2199-2201
280. Rogers S.C., Khalatbari A., Gapper P.W., Frenneau M.P., and James P.E. Detection of human red blood cell-bound nitric oxide. J. Biol. Chem. 280 (2005) 26720-26728
281. Hausladen A., Rafikov R., Angelo M., Singel D.J., Nudler E., and Stamler J.S. Assessment of nitric oxide signals by triiodide chemiluminescence. Proc. Natl. Acad. Sci. USA 104 (2007) 2157-2162
282. Taubert D., Roesen R., Lehmann C., Jung N., and Schömig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. JAMA 298 (2007) 49-60
283. Tsikas D., and Rossi R. Cocoa intake and blood pressure. JAMA 298 (2007) 1862-1863
284. Taubert D., Jung N., and Rosen R. Reply. JAMA 298 (2007) 1863-1864
285. Lipton A.J., Johnson M.A., Macdonald T., Lieberman M.W., Gozal D., and Gaston B. S-Nitrosothiols signal the ventilatory response to hypoxia. Nature 413 (2001) 171-174
286. Zou M.H., Martin C., and Ulrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol. Chem. 378 (1997) 707-713
287. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J.D., Tsikas D., Ertl G., and Bauersachs J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56 (2007) 666-674
288. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., and Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 42 (2006) 601-623
289. Tsikas D., Schwedhelm E., and Frölich J.C. Methodological considerations on the detection of 3-nitrotyrosine in the cardiovascular system. Circ. Res. 90 (2002) e70
290. Ohshima H., Friesen M., Brouet I., and Bartsch H. Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem. Toxicol. 28 (1990) 647-652
291. Baker P.R.S., Schopfer F.J., Sweeney S., and Freeman B.A. Red cell membrane and plasma linoleic acid nitration products: Synthesis, clinical identification, and quantitation. Proc. Natl. Acad. Sci. USA 101 (2004) 11577-11582
292. Kalyanaman B. Nitrated lipids: A class of cell-signaling molecules. Proc. Natl. Acad. Sci. USA 101 (2004) 11527-11528
293. Lima E.S., Bonini M.G., Augusto O., Barbeiro H.V., Souza H.P., and Abdalla D.S.P. Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation. Free Radic. Biol. Med. 39 (2005) 532-539
294. Cui T., Schopfer F.J., Zhang J., Chen K., Ichikawa T., Baker P.R.S., Batthyany C., Chacko B.K., Feng X., Patel R.P., Agarwal A., and Freeman B.A. Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281 (2006) 35686-35698
295. Schopfer F.J., Baker P.R.S., Giles G., Chumley P., Batthyany C., Crawford J., Patel R.P., Hogg N., Branchaud B.P., Lancaster Jr. J.R., and Freeman B.A. Fatty acid transduction of nitric oxide signaling. J. Biol. Chem. 280 (2005) 19289-19297
296. Mitschke A., Gutzki F.-M., and Tsikas D. 9- and 10-nitro-oleic acid do not interfere with the GC-MS quantitative determination of nitrite and nitrate in biological fluids when measured as their pentafluorobenzyl derivatives. J. Chromatogr. B 851 (2007) 287-291
297. Braun O., Knipp M., Chesnov S., and Vasák M. Specific reactions of S-nitrosothiols with cysteine hydrolases: A comparative study between dimethylarginase-1 and CTP synthetase. Protein Sci. 16 (2007) 1-13
298. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsujo H., Reaven G.M., and Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus. Circulation 106 (2002) 987-992
299. Prescott L.M., and Jones M.E. Modified methods for the determination of carbamyl aspartate. Anal. Biochem. 32 (1969) 408-419
300. Tain Y.-L., and Baylis C. Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Intl. 72 (2007) 886-889
301. Lorenzetti R., Lilla S., Donato J.L., and De Nucci G. Simultaneous quantification of GMP, AMP, cyclic GMP, and cyclic AMP by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 859 (2007) 37-41
302. Kempson S., Thompson N., Pezzuto L., and Bohlen H.G. Nitric oxide production by mouse renal tubules can be increased by a sodium-dependent mechanism. Nitric Oxide 17 (2007) 33-43
303. de Bono J.P., Warrick N., Bendall J.K., Channon K.M., and Alp N.J. Radiochemical HPLC detection of arginine metabolism: Measurement of nitric oxide synthesis and arginase activity in vascular tissue. Nitric Oxide 16 (2007) 1-9
304. Hofmann H., and Schmidt H.H.H.W. Thiol dependence of nitric oxide synthase. Biochemistry 34 (1995) 13443-13452
305. Tsikas D., Sandmann J., Lueßen P., Savva A., Rossa S., Stichtenoth D.O., and Frölich J.C. S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat. Biochim. Biophys. Acta 1546 (2001) 422-434
306. Kielstein A., Tsikas D., Galloway G.P., and Mendelson J.E. Asymmetric dimethylarginine (ADMA): A modulator of nociception in opiate tolerance and addiction?. Nitric Oxide 17 (2007) 55-59
307. Smith C.L., Anthony S., Hubank M., Leiper J.M., and Vallance P. Effects of ADMA upon gene expression: An insight into the pathophysiological significance of raised plasma ADMA. PLoS Med. 2 (2005) 1031-1043
308. Braisant O. Measurement of nitric oxide-related enzymes in the brain by in situ hybridization. Methods Mol. Biol. 279 (2004) 113-124
309. Chu Y., and Faraci F.M. Real-time polymerase chain reaction to quantify mRNA for endothelial nitric oxide synthase. Methods Mol. Biol. 279 (2004) 125-132
310. de Belder A.J., MacAllister R., Radomski M.W., Moncada S., and Vallance P.J.T. Effects of S-nitroso-glutathione in the human forearm circulation: Evidence for selective inhibition of platelet activation. Cardiovasc. Res. 28 (1994) 691-694
311. Ramsay B., Radomski M., de Belder A., Martin J.F., and Lopez-Jaramillo P. Systemic effects of S-nitroso-glutathione in the human following intravenous infusion. Br. J. Clin. Pharmacol. 40 (1995) 101-102
312. Tsikas D., Sandmann J., Denker K., and Frölich J.C. Is S-nitrosoglutathione formed in nitric oxide synthase incubates?. FEBS Lett. 483 (2000) 83-85
313. Liu L., Hausladen A., Zeng M., Que L., Heltman J., and Stamler J.S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410 (2001) 490-494
314. Wu H., Romieu I., Sienra-Monge J.-J., del Rio-Navarro B.E., Anderson D.M., Jenchura C.A., Li H., Remirez-Aguilar M., del Carmen Lara-Sanchez I., and London S.J. Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. J. Allergy Clin. Immunol. 120 (2007) 322-328
315. Thompson C.M., and Grafström R.C. Mechanistic considerations for formaldehyde-induced bronchoconstriction involving S-nitrosoglutathione reductase. J. Toxicol. Environ. Health A 71 (2008) 244-248
316. Wu Y., Zhang F., Wang Y., Krishnamoorthy M., Roy-Chaudhury P., Bleske B.E., and Meyerhoff M.E. Photoinstability of S-nitrosothiols during sampling of whole blood: A likely source of error and variability in S-nitrosothiol measurements. Clin. Chem. 54 (2008) 916-918
317. Radabaugh M.R., Nemirovski O.V., Misko T.P., Aggarwal P., and Mathews W.R. Immunoaffinity LC-MS/MS detection of nitrotyrosine in biological fluids: Development of a clinically translatable biomarker. Anal. Biochem. (2008) 10.1016/j.ab.2008.05.019
318. Giustarini D., Rossi R., Milzani A., and Dalle-Donne I. Nitrite and nitrate measurement by Griess reagent in human plasma: Evaluation of interferences and standardization. Methods Enzymol. 440 (2008) 361-380